^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Simulect (basiliximab)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Novartis
Drug class:
CD25 inhibitor
Related drugs:
